Diabetes
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Carr, D. B.
Right arrow Articles by Kahn, S. E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Carr, D. B.
Right arrow Articles by Kahn, S. E.
Social Bookmarking
Add to CiteULike   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Diabetes 53:2087-2094, 2004
© 2004 by the American Diabetes Association, Inc.

Intra-Abdominal Fat Is a Major Determinant of the National Cholesterol Education Program Adult Treatment Panel III Criteria for the Metabolic Syndrome

Darcy B. Carr1, Kristina M. Utzschneider2, Rebecca L. Hull2, Keiichi Kodama2, Barbara M. Retzlaff2, John D. Brunzell2, Jane B. Shofer3, Brian E. Fish2, Robert H. Knopp2, and Steven E. Kahn2

1 Division of Maternal-Fetal Medicine, Department of Obstetrics and Gynecology, University of Washington, Seattle, Washington
2 Division of Metabolism, Endocrinology, and Nutrition, Department of Medicine, Veterans Affairs Puget Sound Health Care System and Harborview Medical Center, University of Washington, Seattle, Washington
3 Department of Rehabilitation Research and Development, University of Washington, Seattle, Washington

The underlying pathophysiology of the metabolic syndrome is the subject of debate, with both insulin resistance and obesity considered as important factors. We evaluated the differential effects of insulin resistance and central body fat distribution in determining the metabolic syndrome as defined by the National Cholesterol Education Program (NCEP) Adult Treatment Panel III. In addition, we determined which NCEP criteria were associated with insulin resistance and central adiposity. The subjects, 218 healthy men (n = 89) and women (n = 129) with a broad range of age (26–75 years) and BMI (18.4–46.8 kg/m2), underwent quantification of the insulin sensitivity index (Si) and intra-abdominal fat (IAF) and subcutaneous fat (SCF) areas. The metabolic syndrome was present in 34 (15.6%) of subjects who had a lower Si [median: 3.13 vs. 6.09 x 10–5 min–1/(pmol/l)] and higher IAF (166.3 vs. 79.1 cm2) and SCF (285.1 vs. 179.8 cm2) areas compared with subjects without the syndrome (P < 0.001). Multivariate models including Si, IAF, and SCF demonstrated that each parameter was associated with the syndrome. However, IAF was independently associated with all five of the metabolic syndrome criteria. In multivariable models containing the criteria as covariates, waist circumference and triglyceride levels were independently associated with Si and IAF and SCF areas (P < 0.001). Although insulin resistance and central body fat are both associated with the metabolic syndrome, IAF is independently associated with all of the criteria, suggesting that it may have a pathophysiological role. Of the NCEP criteria, waist circumference and triglycerides may best identify insulin resistance and visceral adiposity in individuals with a fasting plasma glucose <6.4 mmol/l.

Address correspondence and reprint requests to Darcy B. Carr, MD, Assistant Professor, Box 356460, Dept. OB/GYN, University of Washington, Seattle, WA 98195-6460. E-mail: darcarr{at}u.washington.edu


Add to CiteULike CiteULike   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
 DiabetesHome page
S. Sam, S. Haffner, M. H. Davidson, R. B. D'Agostino Sr., S. Feinstein, G. Kondos, A. Perez, and T. Mazzone
Relationship of Abdominal Visceral and Subcutaneous Adipose Tissue With Lipoprotein Particle Number and Size in Type 2 Diabetes
Diabetes, August 1, 2008; 57(8): 2022 - 2027.
[Abstract] [Full Text] [PDF]

Home page
 J. Clin. Endocrinol. Metab.Home page
R. Barazzoni, M. Zanetti, C. Ferreira, P. Vinci, A. Pirulli, M. Mucci, F. Dore, M. Fonda, B. Ciocchi, L. Cattin, et al.
Relationships between Desacylated and Acylated Ghrelin and Insulin Sensitivity in the Metabolic Syndrome
J. Clin. Endocrinol. Metab., October 1, 2007; 92(10): 3935 - 3940.
[Abstract] [Full Text] [PDF]

Home page
 Am J EpidemiolHome page
J. Luo, K. L. Margolis, H.-O. Adami, A. M. Lopez, L. Lessin, W. Ye, and for the Women's Health Initiative Investigators
Body Size, Weight Cycling, and Risk of Renal Cell Carcinoma among Postmenopausal Women: The Women's Health Initiative (United States)
Am. J. Epidemiol., October 1, 2007; 166(7): 752 - 759.
[Abstract] [Full Text] [PDF]

Home page
 QJMHome page
T. Zornitzki, O. Ayzenberg, G. Gandelman, S. Vered, E. Yaskil, D. Faraggi, A. Caspi, S. Goland, O. Shvez, A. Schattner, et al.
Diabetes, but not the metabolic syndrome, predicts the severity and extent of coronary artery disease in women
QJM, September 1, 2007; 100(9): 575 - 581.
[Abstract] [Full Text] [PDF]

Home page
 J Am Coll CardiolHome page
R. See, S. M. Abdullah, D. K. McGuire, A. Khera, M. J. Patel, J. B. Lindsey, S. M. Grundy, and J. A. de Lemos
The Association of Differing Measures of Overweight and Obesity With Prevalent Atherosclerosis: The Dallas Heart Study
J. Am. Coll. Cardiol., August 21, 2007; 50(8): 752 - 759.
[Abstract] [Full Text] [PDF]

Home page
 J. Clin. Endocrinol. Metab.Home page
E. Ferrannini, B. Balkau, S. W. Coppack, J. M. Dekker, A. Mari, J. Nolan, M. Walker, A. Natali, H. Beck-Nielsen, and the RISC Investigators
Insulin Resistance, Insulin Response, and Obesity as Indicators of Metabolic Risk
J. Clin. Endocrinol. Metab., August 1, 2007; 92(8): 2885 - 2892.
[Abstract] [Full Text] [PDF]

Home page
 Proc. Natl. Acad. Sci. USAHome page
K. F. Petersen, S. Dufour, D. B. Savage, S. Bilz, G. Solomon, S. Yonemitsu, G. W. Cline, D. Befroy, L. Zemany, B. B. Kahn, et al.
Inaugural Article: The role of skeletal muscle insulin resistance in the pathogenesis of the metabolic syndrome
PNAS, July 31, 2007; 104(31): 12587 - 12594.
[Abstract] [Full Text] [PDF]

Home page
 CirculationHome page
C. S. Fox, J. M. Massaro, U. Hoffmann, K. M. Pou, P. Maurovich-Horvat, C.-Y. Liu, R. S. Vasan, J. M. Murabito, J. B. Meigs, L. A. Cupples, et al.
Abdominal Visceral and Subcutaneous Adipose Tissue Compartments: Association With Metabolic Risk Factors in the Framingham Heart Study
Circulation, July 3, 2007; 116(1): 39 - 48.
[Abstract] [Full Text] [PDF]

Home page
 J. Clin. Endocrinol. Metab.Home page
A. Yao-Borengasser, V. Varma, A. M. Bodles, N. Rasouli, B. Phanavanh, M.-J. Lee, T. Starks, L. M. Kern, H. J. Spencer III, A. A. Rashidi, et al.
Retinol Binding Protein 4 Expression in Humans: Relationship to Insulin Resistance, Inflammation, and Response to Pioglitazone
J. Clin. Endocrinol. Metab., July 1, 2007; 92(7): 2590 - 2597.
[Abstract] [Full Text] [PDF]

Home page
 Diabetes CareHome page
G. Pambianco, T. Costacou, and T. J. Orchard
The Prediction of Major Outcomes of Type 1 Diabetes: a 12-Year Prospective Evaluation of Three Separate Definitions of the Metabolic Syndrome and Their Components and Estimated Glucose Disposal Rate: The Pittsburgh Epidemiology of Diabetes Complications Study experience
Diabetes Care, May 1, 2007; 30(5): 1248 - 1254.
[Abstract] [Full Text] [PDF]

Home page
 Circ. Res.Home page
E. Nisoli, E. Clementi, M. O. Carruba, and S. Moncada
Defective Mitochondrial Biogenesis: A Hallmark of the High Cardiovascular Risk in the Metabolic Syndrome?
Circ. Res., March 30, 2007; 100(6): 795 - 806.
[Abstract] [Full Text] [PDF]

Home page
 CirculationHome page
S. C. Smith Jr
Risk Factors for Myocardial Infarction in Latin America: Sobrepeso y Obesidad
Circulation, March 6, 2007; 115(9): 1061 - 1063.
[Full Text] [PDF]

Home page
 Journal of the American Dental AssociationHome page
A. H. Friedlander, J. Weinreb, I. Friedlander, and J. A. Yagiela
Metabolic syndrome: Pathogenesis, medical care and dental implications
J Am Dent Assoc, February 1, 2007; 138(2): 179 - 187.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Respir. Crit. Care Med.Home page
N. McArdle, D. Hillman, L. Beilin, and G. Watts
Metabolic Risk Factors for Vascular Disease in Obstructive Sleep Apnea: A Matched Controlled Study
Am. J. Respir. Crit. Care Med., January 15, 2007; 175(2): 190 - 195.
[Abstract] [Full Text] [PDF]

Home page
 ANGIOLOGYHome page
E. J. Diamantopoulos, E. A. Andreadis, G. I. Tsourous, P. M. Katsanou, D. X. Georgiopoulos, G. D. Dimitriadis, and S. A. Raptis
Intermediate Postchallenge Hyperglycemia in Overweight and Obese Subjects: A New Marker of Impaired Glucose Regulation?
Angiology, January 1, 2007; 57(6): 709 - 716.
[Abstract] [PDF]

Home page
 J. Clin. Endocrinol. Metab.Home page
K. M. Utzschneider and S. E. Kahn
The Role of Insulin Resistance in Nonalcoholic Fatty Liver Disease
J. Clin. Endocrinol. Metab., December 1, 2006; 91(12): 4753 - 4761.
[Abstract] [Full Text] [PDF]

Home page
 J. Clin. Endocrinol. Metab.Home page
E. Ha, M.-J. Kim, B.-K. Choi, J.-J. Rho, D.-J. Oh, T.-H. Rho, K.-H. Kim, H. J. Lee, D.-H. Shin, S. V. Yim, et al.
Positive Association of Obesity with Single Nucleotide Polymorphisms of Syndecan 3 in the Korean Population
J. Clin. Endocrinol. Metab., December 1, 2006; 91(12): 5095 - 5099.
[Abstract] [Full Text] [PDF]

Home page
 J. Lipid Res.Home page
G. Ranganathan, R. Unal, I. Pokrovskaya, A. Yao-Borengasser, B. Phanavanh, B. Lecka-Czernik, N. Rasouli, and P. A. Kern
The lipogenic enzymes DGAT1, FAS, and LPL in adipose tissue: effects of obesity, insulin resistance, and TZD treatment
J. Lipid Res., November 1, 2006; 47(11): 2444 - 2450.
[Abstract] [Full Text] [PDF]

Home page
 J. Clin. Endocrinol. Metab.Home page
G. L. Vega, B. Adams-Huet, R. Peshock, D. Willett, B. Shah, and S. M. Grundy
Influence of Body Fat Content and Distribution on Variation in Metabolic Risk
J. Clin. Endocrinol. Metab., November 1, 2006; 91(11): 4459 - 4466.
[Abstract] [Full Text] [PDF]

Home page
 DiabetesHome page
A. Yao-Borengasser, N. Rasouli, V. Varma, L. M. Miles, B. Phanavanh, T. N. Starks, J. Phan, H. J. Spencer III, R. E. McGehee Jr., K. Reue, et al.
Lipin Expression Is Attenuated in Adipose Tissue of Insulin-Resistant Human Subjects and Increases With Peroxisome Proliferator-Activated Receptor {gamma} Activation.
Diabetes, October 1, 2006; 55(10): 2811 - 2818.
[Abstract] [Full Text] [PDF]

Home page
 J. Clin. Endocrinol. Metab.Home page
J. B. Meigs, P. W. F. Wilson, C. S. Fox, R. S. Vasan, D. M. Nathan, L. M. Sullivan, and R. B. D'Agostino
Body Mass Index, Metabolic Syndrome, and Risk of Type 2 Diabetes or Cardiovascular Disease
J. Clin. Endocrinol. Metab., August 1, 2006; 91(8): 2906 - 2912.
[Abstract] [Full Text] [PDF]

Home page
 Eur J EndocrinolHome page
O Paulmyer-Lacroix, R Desbriere, M Poggi, V Achard, M-C Alessi, F Boudouresque, L. Ouafik, V Vuaroqueaux, M Labuhn, A Dutourand, et al.
Expression of adrenomedullin in adipose tissue of lean and obese women.
Eur. J. Endocrinol., July 1, 2006; 155(1): 177 - 185.
[Abstract] [Full Text] [PDF]

Home page
 Clin. DiabetesHome page
M. Blaha and T. A. Elasy
Clinical Use of the Metabolic Syndrome: Why the Confusion?
Clin. Diabetes, July 1, 2006; 24(3): 125 - 131.
[Abstract] [Full Text] [PDF]

Home page
 Diabetes CareHome page
R. H. Eckel, R. Kahn, R. M. Robertson, and R. A. Rizza
Preventing Cardiovascular Disease and Diabetes: A call to action from the American Diabetes Association and the American Heart Association
Diabetes Care, July 1, 2006; 29(7): 1697 - 1699.
[Full Text] [PDF]

Home page
 CirculationHome page
R. H. Eckel, R. Kahn, R. M. Robertson, and R. A. Rizza
Preventing Cardiovascular Disease and Diabetes: A Call to Action From the American Diabetes Association and the American Heart Association
Circulation, June 27, 2006; 113(25): 2943 - 2946.
[Full Text] [PDF]

Home page
 J Mol EndocrinolHome page
R Buettner, K G Parhofer, M Woenckhaus, C E Wrede, L A Kunz-Schughart, J Scholmerich, and L C Bollheimer
Defining high-fat-diet rat models: metabolic and molecular effects of different fat types.
J. Mol. Endocrinol., June 1, 2006; 36(3): 485 - 501.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Clin. Nutr.Home page
J.-Y. Guh, L.-Y. Chuang, and H.-C. Chen
Betel-quid use is associated with the risk of the metabolic syndrome in adults
Am. J. Clinical Nutrition, June 1, 2006; 83(6): 1313 - 1320.
[Abstract] [Full Text] [PDF]

Home page
 Arterioscler. Thromb. Vasc. Bio.Home page
D. Giugliano and K. Esposito
Optimal Treatments for the Metabolic Syndrome
Arterioscler. Thromb. Vasc. Biol., April 1, 2006; 26(4): e30 - e30.
[Full Text] [PDF]

Home page
 Diabetes CareHome page
J. L. Kuk, T. S. Church, S. N. Blair, and R. Ross
Does Measurement Site for Visceral and Abdominal Subcutaneous Adipose Tissue Alter Associations With the Metabolic Syndrome?
Diabetes Care, March 1, 2006; 29(3): 679 - 684.
[Abstract] [Full Text] [PDF]

Home page
 CirculationHome page
D. Duffy and D. J. Rader
Emerging Therapies Targeting High-Density Lipoprotein Metabolism and Reverse Cholesterol Transport
Circulation, February 28, 2006; 113(8): 1140 - 1150.
[Full Text] [PDF]

Home page
 JAMAHome page
F. X. Pi-Sunyer, L. J. Aronne, H. M. Heshmati, J. Devin, J. Rosenstock, and for the RIO-North America Study Group
Effect of Rimonabant, a Cannabinoid-1 Receptor Blocker, on Weight and Cardiometabolic Risk Factors in Overweight or Obese Patients: RIO-North America: A Randomized Controlled Trial
JAMA, February 15, 2006; 295(7): 761 - 775.
[Abstract] [Full Text] [PDF]

Home page
 Diabetes CareHome page
K. H. Liu, Y. L. Chan, W. B. Chan, J. C. N. Chan, and C. W. W. Chu
Mesenteric Fat Thickness Is an Independent Determinant of Metabolic Syndrome and Identifies Subjects With Increased Carotid Intima-Media Thickness
Diabetes Care, February 1, 2006; 29(2): 379 - 384.
[Abstract] [Full Text] [PDF]

Home page
 GutHome page
E E Frezza, M S Wachtel, and M Chiriva-Internati
Influence of obesity on the risk of developing colon cancer
Gut, February 1, 2006; 55(2): 285 - 291.
[Full Text] [PDF]

Home page
 J. Nutr.Home page
R. J. Wood, J. S. Volek, Y. Liu, N. S. Shachter, J. H. Contois, and M. L. Fernandez
Carbohydrate Restriction Alters Lipoprotein Metabolism by Modifying VLDL, LDL, and HDL Subfraction Distribution and Size in Overweight Men
J. Nutr., February 1, 2006; 136(2): 384 - 389.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Endocrinol. Metab.Home page
C. Hadigan, D. Kamin, J. Liebau, S. Mazza, S. Barrow, M. Torriani, R. Rubin, S. Weise, A. Fischman, and S. Grinspoon
Depot-specific regulation of glucose uptake and insulin sensitivity in HIV-lipodystrophy
Am J Physiol Endocrinol Metab, February 1, 2006; 290(2): E289 - E298.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Clin. Nutr.Home page
R. P Wildman, D. Gu, K. Reynolds, X. Duan, X. Wu, and J. He
Are waist circumference and body mass index independently associated with cardiovascular disease risk in Chinese adults?
Am. J. Clinical Nutrition, December 1, 2005; 82(6): 1195 - 1202.
[Abstract] [Full Text] [PDF]

Home page
 J. Clin. Endocrinol. Metab.Home page
C. Langenberg, J. Bergstrom, G. A. Laughlin, and E. Barrett-Connor
Ghrelin and the Metabolic Syndrome in Older Adults
J. Clin. Endocrinol. Metab., December 1, 2005; 90(12): 6448 - 6453.
[Abstract] [Full Text] [PDF]

Home page
 CirculationHome page
S. M. Grundy, J. I. Cleeman, S. R. Daniels, K. A. Donato, R. H. Eckel, B. A. Franklin, D. J. Gordon, R. M. Krauss, P. J. Savage, S. C. Smith Jr, et al.
Diagnosis and Management of the Metabolic Syndrome: An American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement
Circulation, October 25, 2005; 112(17): 2735 - 2752.
[Full Text] [PDF]

Home page
 J. Clin. Endocrinol. Metab.Home page
C. H. Saely, S. Aczel, T. Marte, P. Langer, G. Hoefle, and H. Drexel
The Metabolic Syndrome, Insulin Resistance, and Cardiovascular Risk in Diabetic and Nondiabetic Patients
J. Clin. Endocrinol. Metab., October 1, 2005; 90(10): 5698 - 5703.
[Abstract] [Full Text] [PDF]

Home page
 Diabetes CareHome page
R. Kahn, J. Buse, E. Ferrannini, and M. Stern
The Metabolic Syndrome: Time for a Critical Appraisal: Joint statement from the American Diabetes Association and the European Association for the Study of Diabetes
Diabetes Care, September 1, 2005; 28(9): 2289 - 2304.
[Abstract] [Full Text] [PDF]

Home page
 DiabetesHome page
O. Sandu, K. Song, W. Cai, F. Zheng, J. Uribarri, and H. Vlassara
Insulin Resistance and Type 2 Diabetes in High-Fat-Fed Mice Are Linked to High Glycotoxin Intake
Diabetes, August 1, 2005; 54(8): 2314 - 2319.
[Abstract] [Full Text] [PDF]

Home page
 CirculationHome page
L. B. Tanko, Y. Z. Bagger, G. Qin, P. Alexandersen, P. J. Larsen, and C. Christiansen
Enlarged Waist Combined With Elevated Triglycerides Is a Strong Predictor of Accelerated Atherogenesis and Related Cardiovascular Mortality in Postmenopausal Women
Circulation, April 19, 2005; 111(15): 1883 - 1890.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Endocrinol. Metab.Home page
T. You, R. Yang, M. F. Lyles, D. Gong, and B. J. Nicklas
Abdominal adipose tissue cytokine gene expression: relationship to obesity and metabolic risk factors
Am J Physiol Endocrinol Metab, April 1, 2005; 288(4): E741 - E747.
[Abstract] [Full Text] [PDF]

Home page
 DiabetesHome page
M.-E. Piche, S. J. Weisnagel, L. Corneau, A. Nadeau, J. Bergeron, and S. Lemieux
Contribution of Abdominal Visceral Obesity and Insulin Resistance to the Cardiovascular Risk Profile of Postmenopausal Women
Diabetes, March 1, 2005; 54(3): 770 - 777.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Diabetes Diabetes Care Clinical Diabetes Diabetes Spectrum
Copyright © 2004 by the American Diabetes Association.